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status (GA+ AA vs. AA). The heart rate variability was obtained into
spectral analysis variables including low (LF) and high frequencies (HF)
and LF/HF ratio (n= 87). Flow-mediated dilation was performed after
30 days (n= 140). Clinical follow-up (n= 331) was carried over until
two years after STEMI and the primary endpoint consisted of fatal and
non-fatal myocardial infarction, unstable angina with hospitalization
and cardiac sudden death. Results: In ANCOVA analysis adjusted for sex
and age, A-allele carriers showed a decreased ﬂow-mediated dilation
[6.13 (7.61) vs 7.29 (6.70); p = 0.025], an increased sympathetic
activity at ﬁrst 24 h [LF/HF 2.29 (3.73) vs 1.55 (2.40); p = 0.026], and it
persists higher between ﬁrst 24 h and ﬁfth day [DeltaLF/HF −0.07
(3.58) vs −0.83 (2.62); p b 0.001]. In the multivariate Cox regression
independent predictors for the primary endpoint were: A-allele carriers
[Relative Risk (RR) = 1.96; 95% Conﬁdence Interval (95% CI): 1.33–
2.90; p = 0.001), arterial hypertension (RR = 2.67; 95% CI: 1.59–4.51;
p b 0.001), age (RR = 1.03; 95% CI: 1.01–1.05; p = 0.002), glycemia at
ﬁfth day (RR = 1.01; 95% CI: 1.00–1.01; p b 0.001) and simvastatin use
in the acute phase (RR = 0.61; 95% CI: 0.39–0.94; p = 0.024).
Conclusions: The presence of the A allele at nNOS gene rs41279104
sequence is associatedwith an impaired endothelial function, increased
sympathetic tone and a higher incidence of recurrent cardiovascular
events after STEMI.
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Introduction: Increased systemic inﬂammatory activity (SIA) during
acute phase of myocardial infarction (MI) is directly associated with the
incidence of lethal ventricular arrhythmias and sudden cardiac death.
Similarly, the extension of the peri-infarct zone (PIZ), as characterized by
cardiac magnetic resonance imaging (CMRI), is associated with the
presence of substrate for generation of ventricular arrhythmias in
patients who recently manifested MI. In this context, this study aims
to: 1) assess whether there is an association between SIA during the
acute phase of MI and the extension of PIZ; 2) assess whether the
emergence of coronary microvascular obstruction, estimated by both
CMRI and coronary angiography, is one of connecting elements between
the SIA and the PIZ; and 3) whether a relationship exists between the
extent of PIZ and the ventricular remodeling after MI, which may
contribute to the link between PIZ and mortality. Methods: We
prospectively included 98 patients (55 ± 10 years) admitted within
12 h ofMIwith ST-segment elevation. Plasma levels of C-reactive protein
(CRP), interleukin-2 (IL-2) and tumor necrosis factor type α (TNF-α)
were assessed at admission (D1) and at the ﬁfth day post-MI (D5). Thirty
days after MI, CMRI was performed to quantify the PIZ and the mass of
MI. Results: BetweenD1 andD5, the relative increases of CRP (6.0 vs. 5.6-
fold, p = 0.02), IL-2 (3.6 vs. 3.4-fold, p = 0.04) and TNF-α (3.9 vs. 4.6-
fold, p = 0.001)were higher in patientswith PIZ above themedian value
(9.98 g) as comparedwith their counterparts. Plasma CRP, IL-2 and TNF-
α at D5 and their respective change from D1 to D5 (delta) were
positively correlated with the extent of PIZ (PCR-D5 r = 0.69,
p b 0.0001; PCR-delta r = 0.7, p b 0.0001; IL-2-D5, r = 0.5, p b 0.0001;
IL-2-delta, r = 0.6, p b 0.0001, TNF-α-D5, r = 0.5, p b 0.0001; TNF-α-
delta, r = 0.4, p = 0.0001). These correlations remained signiﬁcant after
adjustment for age, gender, MI mass and the respective value of these
inﬂammatory mediators assessed at D1. Conclusion: The raise of the SIA
during the acute phase of MI is directly related to the generation of PIZ.
This association should be considered among the potential adverse
effects of excessive increase of AIS during the acute phase of MI.
doi:10.1016/j.bbacli.2015.05.014
A40785
The simvastatin effect on acute inﬂammatory response during ST
elevation myocardial infarction
Bruna Stephany Teles, Jessica Silverio, Jose Carlos Quinaglia e Silva,
Osorio L.R. Almeida, Andrei C. Sposito
Universidade Estadual de Campinas, Campinas, SP, Brazil
Hospital de Base do Distrito Federal, Brasilia, DF, Brazil
Introduction: Following ST Elevation Myocardial Infarction (STEMI),
the ischemic injury motivates an inﬂammatory response, which is a
determinant for myocardial remodeling and mortality. Statin treatment
has shown to attenuate inﬂammatory response in individuals with
hypercholesterolemia and with unstable angina. It is unknown if anti-
inﬂammatory effect may overwhelm the extensive necrosis area in
STEMI and if it is inﬂuenced by the statin therapy. Methods: We
evaluated 247 patients admitted in the ﬁrst 24 h after STEMI. Blood
samples were taken at admission and at the ﬁfth day after STEMI. In a
subgroup, blood samples were daily taken for seven days to determine
the plasma C-reactive protein (CRP). This subgroup was submitted to
nuclear magnetic resonance imaging (MRI) with late enhancement
technique to determine the size of STEMI area. Results:We found aweak
but signiﬁcant correlation between the CRP variation from admission to
the ﬁfth day after STEMI and the peak CK-MB (r = 0.19; p = 0.005). We
did not ﬁnd correlation between STEMI mass and CRP change in the
subgroup of patients submitted toMRI (n= 40). Patients were classiﬁed
in four groups: thosewhowere using statins prior to and duringMI (SS),
statins prior to but not during MI (SN), no statin prior to but during MI
(NS), and no statin prior to nor during MI (NN). Statin users presented a
trend to lower CRP values as compared with those without this
treatment before the MI (NN: 1.0 (0.4–1.5) vs NS: 1.0 (0.3–2.8) vs SS:
0.5 (0.3–1.0) vs SN: 0.6 (0.4–1.0) mg/dL; p = 0.08). By the ﬁfth day, CRP
was signiﬁcantly higher in the SN (18.1 (16.1–23.2)mg/dL) as compared
with other groups (NN: 10.5 (9.3–13.2) vs NS: 2.9 (1.5–4.5) vs SS: 1.1
(0.8–2.4) mg/dL; p b 0.0001). At admission, CRP in the NN group was
lower than in the SN group (p b 0.0001), but higher than the NS and SS
groups (p b 0.0001). Conclusion: The inﬂammatory response, estimated
by CRP, is little or not inﬂuenced by myocardial infarction extension
inferred by CK–MB peak or MRI. The statin withdrawal during STEMI
provokes a rebound inﬂammatory effect. In contrast, prior use of statin
magniﬁes the attenuation of the inﬂammatory response.
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